VEGFR2 Inhibitors [MoA] - N0000020032

Pharmacologic Code	N0000020032
Pharmacologic Name	VEGFR2 Inhibitors
Pharmacologic Uses	human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 2 products whose active ingredient are classified under the same pharmacologic class VEGFR2 Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0002-7669	Cyramza	Non-Proprietary Name: Ramucirumab	Solution	Intravenous	Eli Lilly And Company	ACTIVE
	0002-7678	Cyramza	Non-Proprietary Name: Ramucirumab	Solution	Intravenous	Eli Lilly And Company	ACTIVE